Leggett Thomas 4
4 · Black Diamond Therapeutics, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-17+75,000→ 75,000 totalExercise: $28.69Exp: 2031-02-16→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 17, 2022, with the remainder vesting in 36 equal monthly installments thereafter.